Forum Markets, Inc. (FRMM)
6.00
+0.52
(+9.49%)
USD |
NASDAQ |
Aug 24, 16:00
6.00
0.00 (0.00%)
After-Hours: 20:00
Forum Markets Total Liabilities (Quarterly) : 31.23M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 31.23M |
| March 31, 2026 | 39.28M |
| December 31, 2025 | 67.52M |
| September 30, 2025 | 564.18M |
| June 30, 2025 | 5.334M |
| March 31, 2025 | 3.945M |
| December 31, 2024 | 4.722M |
| September 30, 2024 | 6.736M |
| June 30, 2024 | 4.329M |
| March 31, 2024 | 4.396M |
| December 31, 2023 | 5.387M |
| September 30, 2023 | 5.107M |
| June 30, 2023 | 6.951M |
| March 31, 2023 | 7.782M |
| December 31, 2022 | 23.96M |
| September 30, 2022 | 8.261M |
| June 30, 2022 | 10.57M |
| March 31, 2022 | 18.77M |
| December 31, 2021 | 33.10M |
| Date | Value |
|---|---|
| September 30, 2021 | 27.93M |
| June 30, 2021 | 53.55M |
| March 31, 2021 | 37.40M |
| December 31, 2020 | |
| September 30, 2020 | 6.277M |
| June 30, 2020 | 4.142M |
| March 31, 2020 | 7.238M |
| December 31, 2019 | 7.155M |
| September 30, 2019 | 6.814M |
| June 30, 2019 | 5.456M |
| March 31, 2019 | 5.203M |
| December 31, 2018 | 4.571M |
| September 30, 2018 | 4.692M |
| June 30, 2018 | 4.745M |
| March 31, 2018 | 4.288M |
| December 31, 2017 | 4.233M |
| September 30, 2017 | 4.264M |
| June 30, 2017 | 4.138M |
| March 31, 2017 | 0.3294M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Abeona Therapeutics, Inc. | 51.45M |
| Corcept Therapeutics, Inc. | 182.93M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 159.03M |
| Shareholders Equity (Quarterly) | 127.80M |
| Debt to Equity Ratio | 0.203 |
| Current Ratio | 2.688 |
| Net Debt Paydown Yield | -7.19% |